<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>风云药谈 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-13T23:20:13+08:00</updated>
  <subtitle>分享、交流、学习</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>独家：第四批集采报量与限价预测</title>
    <updated>2020-12-13T23:09:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-13:/s/j0FeoUEXdUfyTxMTF1bLbA</id>
    <link href="https://mp.weixin.qq.com/s/j0FeoUEXdUfyTxMTF1bLbA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>江苏“带量采”很快启动，规则基本清晰！</title>
    <updated>2020-12-11T19:50:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/N_Sk7GBra-KKqXSw_79SWw</id>
    <link href="https://mp.weixin.qq.com/s/N_Sk7GBra-KKqXSw_79SWw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第四批国采深度分析（300亿规模、产品、企业），收藏！</title>
    <updated>2020-12-10T16:24:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/Z4RPmcnSU1RE5gfgZb9F0Q</id>
    <link href="https://mp.weixin.qq.com/s/Z4RPmcnSU1RE5gfgZb9F0Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第四批国采开始报量，44产品、90品规，附产品名单。</title>
    <updated>2020-12-09T12:42:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/WJFm6rzicr4ywDS3p2QIMA</id>
    <link href="https://mp.weixin.qq.com/s/WJFm6rzicr4ywDS3p2QIMA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2021年集采加速，国采符合产品已达78个！</title>
    <updated>2020-12-08T18:35:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/XxT0UYtnzB3G8q4TzK0DAw</id>
    <link href="https://mp.weixin.qq.com/s/XxT0UYtnzB3G8q4TzK0DAw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药代表最值得关注的7个公众号！</title>
    <updated>2020-12-08T18:35:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/VukksGdoKrlay_u0vGiutQ</id>
    <link href="https://mp.weixin.qq.com/s/VukksGdoKrlay_u0vGiutQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国采3进2，代理商的好机会？</title>
    <updated>2020-12-07T18:07:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/HReRpyxTwKBQJUAheiHLDw</id>
    <link href="https://mp.weixin.qq.com/s/HReRpyxTwKBQJUAheiHLDw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>压死未中标产品的“最后一根稻草”，结余留用执行！</title>
    <updated>2020-12-05T17:35:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-05:/s/dWulTZqFz7m12ks7YEzvLQ</id>
    <link href="https://mp.weixin.qq.com/s/dWulTZqFz7m12ks7YEzvLQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>集采会议召开，71个品种会花落谁家？</title>
    <updated>2020-12-04T16:56:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/cUaGROxFDJnOt4y0O_AYWg</id>
    <link href="https://mp.weixin.qq.com/s/cUaGROxFDJnOt4y0O_AYWg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中药集采首重金额，200+过亿产品是热门！</title>
    <updated>2020-12-03T19:19:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/Ki4go-N0MLYgo89ZAHLqOw</id>
    <link href="https://mp.weixin.qq.com/s/Ki4go-N0MLYgo89ZAHLqOw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药代表最值得关注的6个公众号！</title>
    <updated>2020-12-03T19:19:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/2_ipbBmM7DfBUe7VzRq6KQ</id>
    <link href="https://mp.weixin.qq.com/s/2_ipbBmM7DfBUe7VzRq6KQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>江苏“带量采”发布，不看价格看得分！</title>
    <updated>2020-12-02T22:05:28+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/-zmxhMR6tUIP8h1d72Dnug</id>
    <link href="https://mp.weixin.qq.com/s/-zmxhMR6tUIP8h1d72Dnug" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>